The forecast for obstructive airway diseases medicine sales in Italy shows a stable trend from 2024 to 2028, with per capita sales maintaining around 18.6 to 18.7 US Dollars. This indicates minimal growth or decline, signaling a plateau in market conditions. Compared to 2023, the percentage change over the years remains negligible, reflecting a consistent demand without significant fluctuations.

Future trends to watch for include:

Potential impact of new technologies and treatments that may enter the market, potentially altering demand dynamics.
Regulatory changes and healthcare policy reforms in Italy that could affect drug pricing and accessibility.
The aging population trend, which might lead to an overall increase in demand if more individuals develop obstructive airway diseases.